Client or Matter Name
- Client: SK Capital Partners
- Matter: Project Artemis
Deal Description
We represented SK Capital Partners, a private investment firm focused in the pharmaceutical sector, in the acquisition of Apotex Pharmaceutical Holdings Inc. (“Apotex”), a Canadian pharmaceutical company that produces high-quality, affordable medicines across all major therapeutic areas for patients around the world.
The acquisition included several subsidiaries of Apotex, including entities in Canada, the United States, Mexico, India, China, among others.
Jurisdiction
- Canada
- Governing Law
- Canada
Deal Duration, Date of Closing / Signing
- Signing: September 22, 2022
- Closing: April 1, 2023
Practice Area
- Mergers and Acquisitions
Team GC
- Jorge Cervantes – Partner.
- Alberto Bustamante – Counsel.
- Andrés Yépiz – Associate.
- Diego Hernández – Associate.
- Other practice areas involved during diligence.